Terumo's Automated Blood Processing System Cleared for U.S. Commercial Use

Reveos is an automated device to process whole blood into platelets, plasma and red blood cell components in a single centrifugation cycle.

I Stock 637422184
iStock

Terumo Blood and Cell Technologies has received FDA clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle. Automated processing of whole blood on the Reveos system will enhance the blood and platelet supply for patients in the U.S.

Platelets are used to treat patients with many conditions, including trauma and cancer. Today, 94% of platelets available for transfusion in the U.S. come from apheresis, a process that draws a donor's blood, isolates desired components from it, and returns the rest of the blood to the donor, using platforms such as Terumo BCT's Trima Accel Automated Blood Collection System.โ€‹

Apheresis donations are not projected to keep up with increases in platelet usage. FDA's clearance of the automated Reveos system gives blood centers the added capacity to collect platelets from existing whole blood donations efficiently.

In Reveos, Terumo BCT brings to the U.S. a platform with an established track record following deployment in 52 countries over the past decade. Reveos is an automated device to process whole blood into platelets, plasma and red blood cell (RBC) components in a single centrifugation cycle.

Terumo BCT continues making investments to support blood centersโ€‹. In 2022, FDA cleared its IMUGARD WB Platelet Pooling Set, which supports the extended shelf life of platelets from five days to seven days. As part of the Reveos clearance, Terumo BCT obtained an intended use statement for the IMUGARD WB Platelet Pooling Setโ€‹ that includes platelets prepared by Reveos; these platelets can be pooled on day one or day two after collection โ€” providing even more flexibility to blood centers using Reveos.

By automating whole blood processing, Reveos can reduce the working hours needed by laboratory staff by up to 30%. Whole blood is collected from donors and has traditionally been separated into components using manual methods that take as many as 18 or 20 steps. Reveos simplifies this process and eliminates over half the steps.

More in Equipment